SkyQuest Technology Group has recently published a comprehensive Biopreservation Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. Biopreservation is a method which ensures the preservation of the property and functionality of biomass and biological products in a wide range of temperature and other physical conditions. Biomass and biological products can range from DNA, tissues, and organs to stem cells. Recent technological advancement enables the use of microarrays and the integration of diverse predictive models for biopreservation.
Global Biopreservation Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.59 billion in 2024 to USD 26.38 billion by 2032, growing at a CAGR of 28.3% during the forecast period (2025-2032).
Implementation of technology and API algorithms in biopreservation have collectively minimized the time, cost, and complexity associated with the entire process. Additionally, the emergence of multiplex cellular imaging platforms is expected to significantly improve biopreservation capabilities further. Biopreservation finds wider acceptance in cardiology, gynecology, and point-of-care applications. Growing prevalence of chronic diseases worldwide is boosting the development of biological products across various research and development sectors, including immunotherapies, vaccine production, antibody generation, enzyme technology, and biologically derived chemicals.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/biopreservation-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Biopreservation Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region.
Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories.
Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens.
Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications.
Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Biopreservation Market – Regional Analysis:
North America dominated the market and accounted for highest Biopreservation Market share in 2023, driven by flourishing healthcare sector and growing budget for pharmaceutical research. US accounts for the largest market for clinical trials of new drugs and is the powerhouse of drug discovery.
The presence of research centers of large pharmaceutical companies and world class healthcare providers creates high demand for biopreservation of samples required in treatment and research. In addition, the number of cases of chronic disease is significantly high and acceptance of personalized medication using regenerative techniques is also significantly more mature in North America especially in the US.
Asia Pacific is expected to witness the fastest growth in biopreservation demand. The region is the manufacturing hub of medicines and vaccines. China is the largest manufacturer of active pharmaceutical ingredients globally.
Top Market Players in Biopreservation Market are:
Thermo Fisher Scientific Inc. (United States)
Merck KGaA (Germany)
BioLife Solutions, Inc. (United States)
STEMCELL Technologies (Canada)
Helmer Scientific Inc. (United States)
PrincetonCryo (United States)
OPS Diagnostics (United States)
ThermoGenesis Holdings, Inc. (United States)
Avantor, Inc. (United States)
Bio-Techne Corporation (United States)
Exact Sciences Corporation (United States)
Worthington Industries, Inc. (United States)
Chart Industries, Inc. (United States)
Azenta US, Inc. (United States)
LabVantage Solutions, Inc. (United States)
Qiagen N.V. (Netherlands)
Taylor-Wharton Cryogenics LLC (United States)
PHC Holdings Corporation (Japan)
Panasonic Corporation (Japan)
Lifeline Scientific, Inc. (United States)
Biopreservation Market Recent Developments:
In October 2022, Azenta, Inc. bought B Medical Systems S.á r.l. and its affiliated companies, a supplier of temperature-controlled packaging and shipping systems that allow for the global distribution of life-saving medicines.
In July 2022, In Chennai, India, Cellutions BioStorage, a research-to-launch Cryogenic preservation Bank, was opened. Cellutions BioStorage is a full-service biomaterial storage and logistics provider that works with biopharmaceutical businesses that are interested in outsourcing all aspects of their supply chain throughout a product’s life cycle. The newly opened facility is 25,000 square feet in size and features first-rate infrastructure.
You may Also Like
https://issuu.com/skyquest-technology/docs/is_the_global_beer_market_brewing_n_90a1ff0a3d60d8/s/88261823
https://issuu.com/skyquest-technology/docs/autogas_market_overview_revenue_segmentation_an
Forward-Looking Insights
The Biopreservation Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]




